Organization (Other)
Turkiye Yuksek Ihtisas Education and Research Hospital
ClinicalTrials.gov lists Turkiye Yuksek Ihtisas Education and Research Hospital as lead sponsor of 10 trials. It has 2 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Turkiye Yuksek Ihtisas Education and Research Hospital: 10 lead-sponsored trials and 0 legal-entity registrations.
Disease areas (16)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| COVID-19 | 2 |
| Coronary Artery Disease | 1 |
| Coronary Disease | 1 |
| Delirium | 1 |
| Fibrosis | 1 |
Showing 5 of 16 disease areas.
Trials by start year as sponsor or collaborator (8)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2020 | 2 |
| 2019 | 1 |
| 2018 | 1 |
| 2017 | 2 |
| 2016 | 1 |
| 2015 | 2 |
| 2013 | 2 |
| 2011 | 2 |
Recruitment duration, a model prediction: none of the 10 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Approved assets (2)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| (R,S)-ketamine (Pilot I) | 1 |
| Remifentanil | 1 |
Journals published in (10)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Acta obstetricia et gynecologica Scandinavica | 1 |
| Current opinion in obstetrics & gynecology | 1 |
| International journal of clinical practice | 1 |
| International journal of stem cells | 1 |
| Journal of perinatology : official journal of the California Perinatal Association | 1 |
Showing 5 of 10 journals.
Organization relationships (5)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Adana Numune Training and Research Hospital | Co sponsors trial with | 1 |
| Fatih Sultan Mehmet Training and Research Hospital | Co sponsors trial with | 1 |
| Dr. Lutfi Kirdar Kartal Training and Research Hospital | Co sponsors trial with | 1 |
| Kahramanmaras Sutcu Imam University | Co sponsors trial with | 1 |
| Kasımpasa Training and Research Hospital | Co sponsors trial with | 1 |
Latest dated events (13)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2020-03-11 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2020-03-11 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2019-03-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2018-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2017-08-20 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 13 events.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.